✦ LIBER ✦

P.2.127 Treatment of premenstrual disorder in primary assistance: preliminary results

Book ID: 118591898
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 118 KB
Volume: 15
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(05)80916-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.8.070 Escitalopram in the treatment of

P.8.070 Escitalopram in the treatment of premenstrual dysphoric disorder

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Deep brain stimulation in treatment-refa

Deep brain stimulation in treatment-refactory major depressive disorder: Preliminary results in three patients

✍ L. Gabriels; P. Cosyns; B. Nuttin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 40 KB

Etidronate versus fluoride for treatment

Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: Preliminary results after 2 years

✍ N Guanabens; A Pares; A Monegal; P Peris; F Pons; L Alvarez; MJ de Osaba; M Roca 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Preliminary results of 5% immiquimod cre

Preliminary results of 5% immiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3

✍ Tien Le; Wendy Hicks; Chantal Menard; Laura Hopkins; Michael Fung Kee Fung 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 121 KB

P.2.c.005 Use of mesenchymal stem cells

P.2.c.005 Use of mesenchymal stem cells as a novel treatment for bipolar disorder: preliminary results of an in vitro study

✍ Ascoli, B.; Colpo, G.D.; Pfaffenseller, B.; de Aguiar, B. Wollenhaupt; Magrisso, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Lack of beneficial effects of clonidine

Lack of beneficial effects of clonidine in the treatment of premenstrual dysphoric disorder: results of a double-blind, randomized study

✍ Robertas Bunevicius; Alan L. Hinderliter; Kathleen C. Light; Cort A. Pedersen; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Objectives To test the effects of clonidine in comparison with active placebo on premenstrual symptoms, mood scores and norepinephrine (NE) concentration, in women with premenstrual dysphoric disorder (PMDD). Methods Twelve women with prospectively confirmed PMDD were randomly assigned to oral 0.3 m